Usefulness of Tc-99m Sestamibi studies for monitoring response to therapy in patients with high grade gliomas: a preliminary study - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Communication Dans Un Congrès Année : 2015

Usefulness of Tc-99m Sestamibi studies for monitoring response to therapy in patients with high grade gliomas: a preliminary study

Résumé

Early and late Sestamibi studies were acquired in addition to conventional MRI protocol in 14 patients with high-grade gliomas to monitor an antiangiogenic treatment. Global and local indices were deduced from these SPECT studies and were compared with progression free survival (PFS) and overall survival (OS). Variations of intensity in late studies were not correlated with PFS, but were related to OS. This suggests the possible role of Sestamibi for monitoring response to treatment.
Fichier principal
Vignette du fichier
ACTES-RITS2015-HALp48-49.pdf (210.64 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-01143772 , version 1 (20-04-2015)

Licence

Paternité

Identifiants

  • HAL Id : inserm-01143772 , version 1

Citer

Jean-Marc Tacchella, Nathanaelle Yeni, Gregorio Petrirena, Mike-Ely Cohen, Muriel Lefort, et al.. Usefulness of Tc-99m Sestamibi studies for monitoring response to therapy in patients with high grade gliomas: a preliminary study. Journées RITS 2015, Mar 2015, Dourdan, France. pp.48-49. ⟨inserm-01143772⟩
215 Consultations
360 Téléchargements

Partager

Gmail Facebook X LinkedIn More